Vulvar Cancer News and Research

RSS
Vulvar cancer or the cancer of the vulva is a gynaecological cancer that is on the rise with around 1,000 new cases being diagnosed each year in the UK. However, that said, vulvar cancer is rare and accounts for less than 1% of all cancer cases in the UK. North America has the highest incidence and Asia the lowest rates of vulvar cancer.
Study finds critically low HPV vaccination rates among younger adolescents in the U.S.

Study finds critically low HPV vaccination rates among younger adolescents in the U.S.

HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study

HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study

Five important things everyone should know about cervical cancer

Five important things everyone should know about cervical cancer

Study shows women with CIN3 more likely to develop anogenital cancers

Study shows women with CIN3 more likely to develop anogenital cancers

Study demonstrating link between anal cancer and HPV infection published in Obstetrics & Gynecology

Study demonstrating link between anal cancer and HPV infection published in Obstetrics & Gynecology

New NCCN Guidelines published for Vulvar Cancer

New NCCN Guidelines published for Vulvar Cancer

Merck announces availability of GARDASIL 9 HPV vaccine in Canada

Merck announces availability of GARDASIL 9 HPV vaccine in Canada

HPV vaccine does not increase rates of STIs in adolescent females

HPV vaccine does not increase rates of STIs in adolescent females

Japanese mushroom extract shows promise in eradicating HPV

Japanese mushroom extract shows promise in eradicating HPV

Treatment option for women with squamous cell carcinoma of the vulva

Treatment option for women with squamous cell carcinoma of the vulva

High-volume medical centers improve gynecologic cancer survival

High-volume medical centers improve gynecologic cancer survival

MemoryShape Breast Implants receive FDA approval

MemoryShape Breast Implants receive FDA approval

New Cedars-Sinai initiative aims at increasing women's representation in medical research

New Cedars-Sinai initiative aims at increasing women's representation in medical research

SGO's 44th Annual Meeting on Women's Cancer to be held in Los Angeles

SGO's 44th Annual Meeting on Women's Cancer to be held in Los Angeles

Allergan receives FDA approval for Natrelle 410 breast implant

Allergan receives FDA approval for Natrelle 410 breast implant

Sientra receives FDA approval for new silicone gel-filled breast implant

Sientra receives FDA approval for new silicone gel-filled breast implant

HPV-related throat cancer cases increase sharply over the past 10 years

HPV-related throat cancer cases increase sharply over the past 10 years

Study: 30% of older patients with vulvar cancer die from treatment complications, ICD

Study: 30% of older patients with vulvar cancer die from treatment complications, ICD

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Phase III study: GARDASIL prevents 77.5% of pre-cursor lesions to anal cancer

Phase III study: GARDASIL prevents 77.5% of pre-cursor lesions to anal cancer